CD4+ T lymphocytes and viral load in patients with AIDS debut who receive antiretroviral therapy

Journal of AIDS & Clinical Research

ISSN: 2155-6113

Open Access

CD4+ T lymphocytes and viral load in patients with AIDS debut who receive antiretroviral therapy

5th International Conference on HIV/AIDS, STDs and STIs

November 13-14, 2017 Las Vegas, Nevada, USA

Hernandez Requejo D, Perez Avila J and Carr Perez A

Instituto de Medicina Tropical Pedro Kouri, Cuba
Centro de Inmunologia Molecular, Cuba

Posters & Accepted Abstracts: J AIDS Clin Res

Abstract :

Background: AIDS premiere is a form of presentation the illness caused by HIV characterized by alteration of the patient's general state, waste syndrome, opportunist├ó┬?┬?s infections, neoplasia and neurological alterations. Objective: CD4+ T lymphocytes levels and of viral load in patient with AIDS premiere and antiretroviral therapy, were studied to the beginning and one year after the treatment. Methods: A cross sectional prospective observational study was conducted in 55 HIV/AIDS patients, attended in the Medical Services offered by IPK during one year, which had to the beginning of the treatment CD4+ T lymphocytes counts less to 200c├?┬ęl/├?┬ÁL and high viral load. Results: It was observed that there was an average rise of 262 cel per ├?┬ÁL in the CD4+ T-lymphocytes, as well as an average fall of 60 452 cp/├?┬ÁL in viral load one year after the antiretroviral treatment. Conclusions: With this study, we can conclude that after a year of therapy, the values of CD4+ T cells recovered and the viral load levels diminished in the evaluated patients. The results of this study confirm the benefits of antiretroviral therapy, particularly for patient with AIDS premiere

Google Scholar citation report
Citations: 5061

Journal of AIDS & Clinical Research received 5061 citations as per Google Scholar report

Journal of AIDS & Clinical Research peer review process verified at publons

Indexed In

arrow_upward arrow_upward